Page 4 of Glenmark Pharmaceuticals

Glenmark Pharmaceuticals, Nicardipine Hydrochloride Capsules, Cardene capsules, USFDA, Generic drugs, health news, pharma news,

Glenmark Pharmaceuticals gets final nod for its generic chest pain capsules

Nicardipine Hydrochloride Capsules are indicated for to treat severe chest pain (angina) or high blood pressure (hypertension).

December 19, 2022 12:04 IST

Glenmark Pharmaceuticals Rating: neutral; Working on many fronts to improve outlook

GNP to enhance its exiting brand franchise; focus on core therapies

November 22, 2022 02:45 IST

Novo nordisk, Eli Lilly, Type 2 diabetes market, health news, pharma news,

Glenmark becomes first to launch Lobeglitazone for uncontrolled Type 2 Diabetes in India

According to the company, the drug will be marketed under the brand name LOBG and it contains Lobeglitazone (0.5 mg).

October 6, 2022 11:01 IST

Glenmark, Glenmark Pharmaceuticals, Type 2 Diabetes, fixed-dose combination, health news, pharma news,

Bausch Health and Glenmark announce approval of Hay fever nasal spray in Canada

According to the company, RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal…

September 23, 2022 16:04 IST

Glenmark Pharmaceuticals, glenmark pharma, healthcare news, pharma news,

Glenmark Pharma gets approval from Health Canada for nasal spray Ryaltris

Health Canada granted approval to partner Bausch Health Companies Inc and Glenmark Specialty SA, a subsidiary of the company, for…

Updated: September 23, 2022 13:12 IST

Hikma launches RYALTRIS seasonal allergic rhinitis nasal spray in US

According to the company, RYALTRIS is the only fixed-dose combination therapy that provides relief for the symptoms of SAR, both…

August 30, 2022 18:41 IST

Glenmark Pharma’s shares weak in trade as firm announces recall of generic skin ointment in United States

According to reports, the regulatory scrutiny of the Indian drug makers has increased this year, as the USFDA reconvened physical…

August 16, 2022 20:32 IST

Dr. Reddy's, Dr Reddy's labs, Difluprednate Ophthalmic Emulsion, eye drops, eye care, health news, pharma news,

Pharma majors Glenmark, Sun Pharma and Dr Reddy’s recall products in United States

In the last financial year, India’s pharma exports stood at around USD 24.62 billion with the US, the UK, South…

August 15, 2022 19:06 IST

Glenmark Pharmaceuticals announces Q1 Results; Profit declines 31% to Rs 211.1 crore

Meanwhile, the revenue from operations declined to Rs 2,777 crore in the June quarter as compared with Rs 2,965 crore…

August 11, 2022 12:07 IST

Glenmark Pharmaceuticals receives ANDA approval for generic version of Taytulla Capsules

Meanwhile, Glenmark’s current portfolio consists of 177 products authorised for distribution in the U.S. marketplace and 47 ANDA’s pending approval…

July 29, 2022 17:58 IST

Sun Pharma, Glenmark, USFDA, health news, pharma news,

Sun Pharma, Glenmark recall products due to manufacturing issues in United States

Reportedly, the Mumbai-based drug major is recalling the affected lot due to “water leakage” leading to deviation from current good…

July 25, 2022 18:08 IST

Glenmark Pharmaceutical, Sanotize, Nasal Spray, COVID-19 nasal spray, health news, COVID-19 news,

Glenmark Pharmaceuticals and SaNOtize announce their Phase 3 Clinical Trials results on novel nasal spray for COVID-19

The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained…

July 13, 2022 18:37 IST

Glenmark pharmaceuticals, acne, pimples, puberty, Minocycline gel, health news, pharma news,

Glenmark Pharmaceuticals launches India’s first Topical Minocycline 4% Gel for moderate to severe acne

MINYM® Gel (Topical Minocycline 4% Gel) has been developed to address these growing concerns in the treatment of acne and…

July 11, 2022 12:58 IST

Glenmark Pharma launches gel for acne treatment

Minocycline 4 per cent gel is a potent antibacterial gel that exerts a strong anti-inflammatory action. It also offers the…

July 11, 2022 11:36 IST

Glenmark, Sitagliptin, Type 2 diabetes, health news, phama news,

Glenmark launches Sitagliptin and its fixed-dose combinations at affordable price for Adults with Type 2 Diabetes in India

Moreover, in India, patients have to bear the drug cost on their own and so the price of the drug…

July 7, 2022 13:37 IST

Pharmaceutical sector, Indian pharmaceutical sector, India colombo relations, health news, pharma news,

Glenmark USA continues to expand its Over-The-Counter Portfolio with acquisition of new drugs from Wockhardt Limited

Currently, Glenmark’s portfolio consists of 175 products authorized for distribution in the U.S. marketplace and 48 ANDAs pending approval with…

June 28, 2022 14:02 IST

Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US

The acquisition by the company’s fully-owned subsidiary Glenmark Pharmaceuticals Inc, USA includes the approved abbreviated new drug applications (ANDAs) for…

June 28, 2022 11:27 IST

Glenmark Pharma launches Whatsapp chatbot to help patients with fungal infections

The Mumbai-based drugmaker has developed the digital patient education tool ‘Hello Skin’ in collaboration with the IADVL (Indian Association of…

May 24, 2022 13:55 IST

Related News

Aadhaar Card Update: Simple step-by-step guide to change your address online without hassle

Aadhaar Card Update: How to change address in Aadhaar Card online in simple steps

Florida Governor Hopeful James Fishback Vows to “Fire Every H‑1B” in State Agencies

‘ll fire every H-1B worker’: Florida Governor hopeful pledges to incentivise firms to hire Americans

New rent rules 2025: Mandatory online registration, limited deposits – Here’s all you need to know

Ajay Devgn and Kajol’s luxurious 5BHK Goa villa

Step inside Ajay Devgn–Kajol’s lavish 5BHK villa: Luxury pool, stunning interiors and a 100-year-old well

Indians among largest group to leave UK amid migration drop

74,000 Indians leave UK as net migration drops 80%, skilled worker visas plunge

‘US should not shutdown H-1B visa’, Elon Musk tells Nikhil Kamath

Business14 min ago

Nikhil Kamath’s ‘WTF is’ podcast with Elon Musk has caused a buzz on social media. The duo covered topics like the H-1B visa program and Indian talent. Musk praised Indian talent but criticized misuse of the program. He also urged Indians to be positive contributors to society. The podcast is known for its uncensored conversations with tech and business leaders.

View all shorts